EUROPEAN JOURNAL OF ENDOCRINOLOGY, cilt.184, sa.4, ss.553-563, 2021 (SCI-Expanded, Scopus)
Objective: Despite published guidelines no unified approach to hormone replacement in congenital adrenal hyperplasia (CAH) exists. We aimed to explore geographical and temporal variations in the treatment with glucocorticoids and mineralocorticoids in CAH.